Doctor profile · Federal record
Dr. Charles Eifrig, M.D.
Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Laguna Hills, CA
- NPI 1306812979
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 29 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
23521 Paseo de Valencia, Suite 207 (Taj Majal Building)
Laguna Hills, CA 926533107
(949) 707-5125
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- March 31, 2017
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State licenses (2)
- California #C53104 · North Carolina #200300335
- Medicaid (2)
- NC #89134EF · NC #89014T8
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306812979. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
34,604
Distinct HCPCS
10
Medicare allowed
$3,329,922
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 18,720 | 56 | $37 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 5,440 | 182 | $223 | |
92134 |
Imaging of retina | 3,290 | 1,206 | $46 | |
67028 |
Injection of drug into eye | 2,010 | 305 | $126 | |
92202 |
Extended exam of the back part of the eye with optic nerve drawing | 1,663 | 1,020 | $17 | |
92014 |
Established patient complete exam of visual system | 1,370 | 958 | $143 | |
J0178 |
Injection, aflibercept, 1 mg | 778 | 66 | $844 | |
92012 |
Established patient problem focused exam of visual system | 375 | 243 | $102 | |
92201 |
Extended exam of the back part of the eye with retinal drawing | 347 | 260 | $27 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 187 | 187 | $181 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,922. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$53,871
Transactions
80
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genentech USA, Inc. | 46 | $36,893.82 | |
| Alcon Research LLC | 4 | $11,000.00 | |
| Regeneron Pharmaceuticals, Inc. | 2 | $2,529.00 | |
| Beaver-Visitec International, Inc. | 1 | $2,100.00 | |
| Alcon Vision LLC | 8 | $699.76 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $214.36 | |
| Astellas Pharma US Inc | 5 | $125.57 | |
| Genentech, Inc. | 1 | $114.89 | |
| ABBVIE INC. | 3 | $63.86 | |
| Sandoz Inc. | 2 | $45.15 | |
| Apellis Pharmaceuticals, Inc. | 1 | $32.10 | |
| Coherus Biosciences Inc. | 1 | $19.96 | |
| Alimera Sciences, Inc. | 1 | $19.14 | |
| Astellas Pharma Global Development | 1 | $13.68 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
208
Patients
130
Total drug cost
$10,421
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 61 | 32 | $1,893 |
| Ketorolac Tromethamine | Generic | 54 | 22 | $1,224 |
| Tobramycin-Dexamethasone (Tobramycin/Dexamethasone) | Brand | 49 | 47 | $2,885 |
| Difluprednate | Generic | 31 | 29 | $4,265 |
| Diclofenac Sodium | Generic | 13 | 0 | $153 |
Frequently asked questions
What is Dr. Charles Eifrig's medical specialty?
Dr. Charles Eifrig practices Retina Specialist (Ophthalmology) Physician in Laguna Hills, CA.
Where does Dr. Charles Eifrig practice?
Dr. Charles Eifrig practices at 23521 Paseo de Valencia, Laguna Hills, CA 926533107. Office phone: 9497075125.
What is Dr. Charles Eifrig's NPI?
Dr. Charles Eifrig's National Provider Identifier (NPI) is 1306812979, issued by NPPES.
Does Dr. Charles Eifrig accept Medicare assignment?
Yes. Dr. Charles Eifrig accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Eifrig commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, ranibizumab, 0.1 mg (HCPCS J2778); Imaging of retina (HCPCS 92134). Source: CMS Medicare Physician & Other Practitioners file.